Colosimo, S., Miller, H., Koutoukidis, D. A., Marjot, T., Tan, G. D., Harman, D. J., Aithal, G. P., Manousou, P., Forlano, R., Parker, R., Sheridan, D. A., Newsome, P. N., Alazawi, W., Cobbold, J. F., & Tomlinson, J. W. (2024). Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD. Diabetes Research and Clinical Practice, 217, Article 111820. https://doi.org/10.1016/j.diabres.2024.111820